News | July 16, 2024
Merck completes acquisition of EyeBio
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine
Directs officials to ensure that challenges hampering their effective implementation are resolved early in coordination with states
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
The facility is a part of Lupin Manufacturing Solutions
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
Sacubitril and Valsartan combination is used to treat chronic heart failure in adults
KIMS already have a multi-specialty hospital and gastro unit at Vizag
Subscribe To Our Newsletter & Stay Updated
